Forwarded from Doomsday Tradecraft
🧬 Biotechnology is changing how we fight disease—and opening new possibilities for human health.
Four advances from September 2026:
🔬 ONE MEDICINE, TWO GENE TARGETS
Arrowhead’s experimental ARO-DIMER-PA suppresses PCSK9 and APOC3 together. Early results reported mean maximum reductions of 54% in LDL cholesterol and 73% in triglycerides after one dose. Whether it prevents heart attacks or strokes remains unproven.
🛡️ REACTIVATING IMMUNITY AGAINST CANCER
In 87 patients with previously treated metastatic squamous lung cancer, gotistobart produced median survival of 18.5 months versus 10 months with chemotherapy. These encouraging results still need confirmation in the pivotal portion of the trial.
💪 TARGETING MUSCLE LOSS
The FDA approved Isembyld for spinal muscular atrophy in patients aged 2+ receiving SMN2-targeted treatment. It blocks activation of myostatin—a natural brake on muscle growth—and demonstrated improved motor function.
⏳ INVESTIGATING BIOLOGICAL AGING
An analysis of 42 lung-fibrosis trial participants found that rentosertib shifted blood-protein aging estimates toward younger profiles. This does not yet prove rejuvenation or longer life.
The progress is real. Understanding the evidence helps us see how far each discovery has actually reached.
Sources: Arrowhead • BioNTech/OncoC4 • FDA/Scholar Rock • Nature Biotechnology
#Biotechnology #MedicalBreakthroughs #RNAtherapeutics #CancerResearch #LongevityScience
Four advances from September 2026:
🔬 ONE MEDICINE, TWO GENE TARGETS
Arrowhead’s experimental ARO-DIMER-PA suppresses PCSK9 and APOC3 together. Early results reported mean maximum reductions of 54% in LDL cholesterol and 73% in triglycerides after one dose. Whether it prevents heart attacks or strokes remains unproven.
🛡️ REACTIVATING IMMUNITY AGAINST CANCER
In 87 patients with previously treated metastatic squamous lung cancer, gotistobart produced median survival of 18.5 months versus 10 months with chemotherapy. These encouraging results still need confirmation in the pivotal portion of the trial.
💪 TARGETING MUSCLE LOSS
The FDA approved Isembyld for spinal muscular atrophy in patients aged 2+ receiving SMN2-targeted treatment. It blocks activation of myostatin—a natural brake on muscle growth—and demonstrated improved motor function.
⏳ INVESTIGATING BIOLOGICAL AGING
An analysis of 42 lung-fibrosis trial participants found that rentosertib shifted blood-protein aging estimates toward younger profiles. This does not yet prove rejuvenation or longer life.
The progress is real. Understanding the evidence helps us see how far each discovery has actually reached.
Sources: Arrowhead • BioNTech/OncoC4 • FDA/Scholar Rock • Nature Biotechnology
#Biotechnology #MedicalBreakthroughs #RNAtherapeutics #CancerResearch #LongevityScience
🔥1
Forwarded from Doomsday Tradecraft
WILL HUMANITY REMAIN ABOVE AI?
Many people fear that artificial intelligence will eventually surpass humanity. But fear alone will not protect us—and slowing AI indefinitely may also limit extraordinary progress in science, medicine, energy and space exploration.
We should allow AI intelligence to advance rapidly while ensuring that human capability evolves with it.
AI possesses extraordinary advantages:
• Vast information storage
• Rapid computation
• Pattern recognition
• Global scalability
Humans retain different strengths:
• Intuition
• Meaning and purpose
• Moral responsibility
• Embodied experience
• Creativity and wisdom
However, these advantages will matter only if we continue developing them.
The next stage of human evolution may emerge through advanced biophysics:
🧬 Regenerative medicine to repair cells and organs
🧠 Neural augmentation to strengthen memory and cognition
⏳ Longevity science to slow aging and resist disease
🔬 Cognitive preservation to protect identity and experience
🤝 Human–AI symbiosis that keeps AI as an instrument—not a sovereign
Biological and mental immortality remains a scientific aspiration, not a demonstrated capability. Yet research into cellular rejuvenation, brain–computer interfaces, neuroprosthetics and cognitive preservation may gradually extend both human life and human capability.
At the same time, advanced AI must remain governed by human-defined goals, restricted access, independent oversight, shutdown mechanisms and recovery systems. Humanity created AI; humanity must retain the authority to direct it.
This is not about destroying AI or teaching it to fear us. It is about becoming capable enough that no artificial system can independently control civilization.
AI can help humanity advance exponentially—but human wisdom must determine the destination.
Humanity becomes cosmic not by suppressing intelligence, but by mastering itself, governing its creations and expanding responsibly beyond Earth.
FROM HUMANITY TO COSMIC CIVILIZATION.
#HumanEvolution #ArtificialIntelligence #Biophysics #LongevityScience #CosmicCivilization
Many people fear that artificial intelligence will eventually surpass humanity. But fear alone will not protect us—and slowing AI indefinitely may also limit extraordinary progress in science, medicine, energy and space exploration.
We should allow AI intelligence to advance rapidly while ensuring that human capability evolves with it.
AI possesses extraordinary advantages:
• Vast information storage
• Rapid computation
• Pattern recognition
• Global scalability
Humans retain different strengths:
• Intuition
• Meaning and purpose
• Moral responsibility
• Embodied experience
• Creativity and wisdom
However, these advantages will matter only if we continue developing them.
The next stage of human evolution may emerge through advanced biophysics:
🧬 Regenerative medicine to repair cells and organs
🧠 Neural augmentation to strengthen memory and cognition
⏳ Longevity science to slow aging and resist disease
🔬 Cognitive preservation to protect identity and experience
🤝 Human–AI symbiosis that keeps AI as an instrument—not a sovereign
Biological and mental immortality remains a scientific aspiration, not a demonstrated capability. Yet research into cellular rejuvenation, brain–computer interfaces, neuroprosthetics and cognitive preservation may gradually extend both human life and human capability.
At the same time, advanced AI must remain governed by human-defined goals, restricted access, independent oversight, shutdown mechanisms and recovery systems. Humanity created AI; humanity must retain the authority to direct it.
This is not about destroying AI or teaching it to fear us. It is about becoming capable enough that no artificial system can independently control civilization.
AI can help humanity advance exponentially—but human wisdom must determine the destination.
Humanity becomes cosmic not by suppressing intelligence, but by mastering itself, governing its creations and expanding responsibly beyond Earth.
FROM HUMANITY TO COSMIC CIVILIZATION.
#HumanEvolution #ArtificialIntelligence #Biophysics #LongevityScience #CosmicCivilization